Table 3.
Antimicrobial resistance percentages of 142 ESBL-EC strains.
| Experimental groups | Antimicrobial agents tested |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| SAM | CIP | GEN | STX | AMC | TZP | AMK∗ | FEP | IMI | ERT | |
| Urine (83) | ||||||||||
| Hospitalized patients (47) | 82 | 73.3 | 42.3 | 74.5 | 51.2 | 30 | 5 | 100 | 2.2 | 2.2 |
| Outpatients (n = 36) | 79.2 | 60.5 | 24.4 | 60.2 | 47.6 | 20 | 0 | 100 | 0 | 0 |
| Blood (n = 59) | 95 | 67.8 | 48 | 78 | 59.5 | 40.7 | 3.4 | 96.6 | 5.1 | 3.4 |
SAM, ampicillin/sulbactam; CIP, ciprofloxacin; GEN, gentamicin; STX, sulfamethoxazole; AMC, amoxicillin-clavulanate; TZP, piperacillin/tazobactam; AMK, amikacin; FEP, cefepime; IMI, imipenem; ERT, ertapenem. ∗Reduce susceptibility.